{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:07:27Z","timestamp":1793142447963,"version":"4.5.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09964-x","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T07:02:05Z","timestamp":1727506925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The role of neuron-like cell lines and primary neuron cell models in unraveling the complexity of neurodegenerative diseases: a comprehensive review"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3023-9524","authenticated-orcid":false,"given":"Kianoush","family":"Ghiasvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3952-4851","authenticated-orcid":false,"given":"Mehdi","family":"Amirfazli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6792-8987","authenticated-orcid":false,"given":"Fatemeh","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3506-7753","authenticated-orcid":false,"given":"Mohammad Ali","family":"Takhshid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"2","key":"9964_CR1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/fn.2020.96707","volume":"58","author":"R Armstrong","year":"2020","unstructured":"Armstrong R (2020) What causes neurodegenerative disease? Folia Neuropathol 58(2):93\u2013112","journal-title":"Folia Neuropathol"},{"key":"9964_CR2","doi-asserted-by":"crossref","unstructured":"(2024) Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20(5):3708\u2009\u2013\u2009821","DOI":"10.1002\/alz.13809"},{"issue":"4","key":"9964_CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"regional Global","year":"2024","unstructured":"Global regional (2024) National burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the global burden of Disease Study 2021. Lancet Neurol 23(4):344\u2013381","journal-title":"Lancet Neurol"},{"key":"9964_CR4","doi-asserted-by":"crossref","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J (2022) A review of the Common Neurodegenerative disorders: current therapeutic approaches and the potential role of Nanotherapeutics. Int J Mol Sci. ;23(3)","DOI":"10.3390\/ijms23031851"},{"issue":"7","key":"9964_CR5","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled D, Strasser A, Liddell JR (2021) Molecular mechanisms of cell death in neurological diseases. Cell Death Differ 28(7):2029\u20132044","journal-title":"Cell Death Differ"},{"key":"9964_CR6","doi-asserted-by":"crossref","unstructured":"Agnello L, Ciaccio M (2022) Neurodegenerative diseases: from molecular basis to Therapy. Int J Mol Sci. ;23(21)","DOI":"10.3390\/ijms232112854"},{"key":"9964_CR7","doi-asserted-by":"crossref","unstructured":"Krassner MM, Kauffman J, Sowa A, Cialowicz K, Walsh S, Farrell K et al (2023) Postmortem changes in brain cell structure: a review. Free Neuropathology. ;4","DOI":"10.31219\/osf.io\/gj29w"},{"issue":"1","key":"9964_CR8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s40478-023-01649-z","volume":"11","author":"Y Pomeshchik","year":"2023","unstructured":"Pomeshchik Y, Velasquez E, Gil J, Klementieva O, Gidl\u00f6f R, Sydoff M et al (2023) Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer\u2019s disease pathogenesis. Acta Neuropathol Commun 11(1):150","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"9964_CR9","first-page":"192","volume":"2","author":"Q-Q Xu","year":"2023","unstructured":"Xu Q-Q, Yang W, Zhong M, Lin Z-X, Gray NE, Xian Y-F (2023) Animal models of Alzheimer\u2019s disease: preclinical insights and challenges. Acta Materia Med 2(2):192\u2013215","journal-title":"Acta Materia Med"},{"key":"9964_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-981-16-2830-6_14","volume":"1208","author":"R Huang","year":"2021","unstructured":"Huang R, Wu S (2021) Cell models in Autophagy Research. Adv Exp Med Biol 1208:311\u2013332","journal-title":"Adv Exp Med Biol"},{"key":"9964_CR11","doi-asserted-by":"crossref","unstructured":"B\u00e9dard P, Gauvin S, Ferland K, Caneparo C, Pellerin \u00c8, Chabaud S et al (2020) Innovative human three-dimensional tissue-Engineered models as an alternative to animal testing. Bioeng (Basel). ;7(3)","DOI":"10.3390\/bioengineering7030115"},{"key":"9964_CR12","doi-asserted-by":"crossref","unstructured":"Chia SJ, Tan EK, Chao YX (2020) Historical Perspective: Models of Parkinson\u2019s Disease. Int J Mol Sci. ;21(7)","DOI":"10.3390\/ijms21072464"},{"issue":"5","key":"9964_CR13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s43587-023-00410-4","volume":"3","author":"MS Rafii","year":"2023","unstructured":"Rafii MS, Aisen PS (2023) Detection and treatment of Alzheimer\u2019s disease in its preclinical stage. Nat Aging 3(5):520\u2013531","journal-title":"Nat Aging"},{"key":"9964_CR14","doi-asserted-by":"crossref","first-page":"1263771","DOI":"10.3389\/fnins.2023.1263771","volume":"17","author":"A Pless","year":"2023","unstructured":"Pless A, Ware D, Saggu S, Rehman H, Morgan J, Wang Q (2023) Understanding neuropsychiatric symptoms in Alzheimer\u2019s disease: challenges and advances in diagnosis and treatment. Front NeuroSci 17:1263771","journal-title":"Front NeuroSci"},{"issue":"3","key":"9964_CR15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s40136-023-00463-4","volume":"11","author":"J Wu","year":"2023","unstructured":"Wu J, Burdick R, Deckelman C, Gustafson S, Yee J, Rogus-Pulia N (2023) Management of Dysphagia in neurodegenerative disease. Curr Otorhinolaryngol Rep 11(3):352\u2013364","journal-title":"Curr Otorhinolaryngol Rep"},{"key":"9964_CR16","doi-asserted-by":"crossref","first-page":"1016559","DOI":"10.3389\/fnmol.2022.1016559","volume":"15","author":"D Xie","year":"2022","unstructured":"Xie D, Deng T, Zhai Z, Sun T, Xu Y (2022) The cellular model for Alzheimer\u2019s disease research: PC12 cells. Front Mol Neurosci 15:1016559","journal-title":"Front Mol Neurosci"},{"key":"9964_CR17","doi-asserted-by":"crossref","unstructured":"Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodr\u00edguez I, Cadena-Su\u00e1rez AR, S\u00e1nchez-Garibay C et al (2023) Alzheimer\u2019s Disease: An Updated Overview of Its Genetics. Int J Mol Sci. ;24(4)","DOI":"10.3390\/ijms24043754"},{"key":"9964_CR18","doi-asserted-by":"crossref","first-page":"102278","DOI":"10.1016\/j.arr.2024.102278","volume":"96","author":"AE Morgan","year":"2024","unstructured":"Morgan AE, Mc Auley MT (2024) Vascular dementia: from pathobiology to emerging perspectives. Ageing Res Rev 96:102278","journal-title":"Ageing Res Rev"},{"issue":"3","key":"9964_CR19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/cells10030656","volume":"10","author":"D Koziorowski","year":"2021","unstructured":"Koziorowski D, Figura M, Milanowski \u0141M, Szlufik S, Alster P, Madetko N et al (2021) Mechanisms of neurodegeneration in various forms of parkinsonism\u2014similarities and differences. Cells 10(3):656","journal-title":"Cells"},{"key":"9964_CR20","doi-asserted-by":"crossref","unstructured":"Cherian A, Divya K Genetics of Parkinson\u2019s disease. Acta Neurol Belgica. 2020:1\u20139","DOI":"10.1007\/s13760-020-01473-5"},{"issue":"1","key":"9964_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41531-023-00568-z","volume":"9","author":"M Tsalenchuk","year":"2023","unstructured":"Tsalenchuk M, Gentleman SM, Marzi SJ (2023) Linking environmental risk factors with epigenetic mechanisms in Parkinson\u2019s disease. Npj Parkinson\u2019s Disease 9(1):123","journal-title":"Npj Parkinson\u2019s Disease"},{"key":"9964_CR22","doi-asserted-by":"crossref","first-page":"736978","DOI":"10.3389\/fmed.2021.736978","volume":"8","author":"E Srinivasan","year":"2021","unstructured":"Srinivasan E, Chandrasekhar G, Chandrasekar P, Anbarasu K, Vickram A, Karunakaran R et al (2021) Alpha-synuclein aggregation in Parkinson\u2019s disease. Front Med 8:736978","journal-title":"Front Med"},{"key":"9964_CR23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pharmthera.2019.01.001","volume":"197","author":"A Kanthasamy","year":"2019","unstructured":"Kanthasamy A, Jin H, Charli A, Vellareddy A, Kanthasamy A (2019) Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms. Pharmacol Ther 197:61\u201382","journal-title":"Pharmacol Ther"},{"issue":"1","key":"9964_CR24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.14336\/AD.2020.0331","volume":"12","author":"M Ke","year":"2021","unstructured":"Ke M, Chong CM, Zhu Q, Zhang K, Cai CZ, Lu JH et al (2021) Comprehensive perspectives on experimental models for Parkinson\u2019s Disease. Aging Dis 12(1):223\u2013246","journal-title":"Aging Dis"},{"issue":"1\u20132","key":"9964_CR25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/21678421.2022.2053722","volume":"24","author":"S Sennf\u00e4lt","year":"2023","unstructured":"Sennf\u00e4lt S, Kl\u00e4ppe U, Thams S, Samuelsson K, Press R, Fang F et al (2023) The path to diagnosis in ALS: delay, referrals, alternate diagnoses, and clinical progression. Amyotroph Lateral Scler Frontotemporal Degeneration 24(1\u20132):45\u201353","journal-title":"Amyotroph Lateral Scler Frontotemporal Degeneration"},{"key":"9964_CR26","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","volume":"13","author":"R Mejzini","year":"2019","unstructured":"Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA (2019) ALS Genetics, mechanisms, and therapeutics: where are we now? Front Neurosci 13:1310","journal-title":"Front Neurosci"},{"issue":"1","key":"9964_CR27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41598-021-03891-8","volume":"12","author":"M Berdy\u0144ski","year":"2022","unstructured":"Berdy\u0144ski M, Miszta P, Safranow K, Andersen PM, Morita M, Filipek S et al (2022) SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity. Sci Rep 12(1):103","journal-title":"Sci Rep"},{"key":"9964_CR28","doi-asserted-by":"crossref","first-page":"101790","DOI":"10.1016\/j.arr.2022.101790","volume":"83","author":"P Soares","year":"2023","unstructured":"Soares P, Silva C, Chavarria D, Silva FSG, Oliveira PJ, Borges F (2023) Drug discovery and amyotrophic lateral sclerosis: emerging challenges and therapeutic opportunities. Ageing Res Rev 83:101790","journal-title":"Ageing Res Rev"},{"key":"9964_CR29","doi-asserted-by":"crossref","unstructured":"Sever B, Ciftci H, DeMirci H, Sever H, Ocak F, Yulug B et al (2022) Comprehensive Research on Past and Future therapeutic strategies devoted to treatment of amyotrophic lateral sclerosis. Int J Mol Sci. ;23(5)","DOI":"10.3390\/ijms23052400"},{"issue":"6","key":"9964_CR30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/nmt-2020-0033","volume":"10","author":"Y Saitoh","year":"2020","unstructured":"Saitoh Y, Takahashi Y (2020) Riluzole for the treatment of amyotrophic lateral sclerosis. Neurodegener Dis Manag 10(6):343\u2013355","journal-title":"Neurodegener Dis Manag"},{"issue":"1\u20132","key":"9964_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/21678421.2019.1632346","volume":"21","author":"JS Mora","year":"2020","unstructured":"Mora JS, Genge A, Chio A, Estol CJ, Chaverri D, Hern\u00e1ndez M et al (2020) Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotroph Lateral Scler Frontotemporal Degener 21(1\u20132):5\u201314","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"9964_CR32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1087057113501553","volume":"19","author":"JD Boyd","year":"2014","unstructured":"Boyd JD, Lee-Armandt JP, Feiler MS, Zaarur N, Liu M, Kraemer B et al (2014) A high-content screen identifies novel compounds that inhibit stress-induced TDP-43 cellular aggregation and associated cytotoxicity. J BioMol Screen 19(1):44\u201356","journal-title":"J BioMol Screen"},{"issue":"8","key":"9964_CR33","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.3390\/ijms22083977","volume":"22","author":"F Liguori","year":"2021","unstructured":"Liguori F, Amadio S, Volont\u00e9 C (2021) Where and why modeling amyotrophic lateral sclerosis. Int J Mol Sci 22(8):3977","journal-title":"Int J Mol Sci"},{"issue":"11","key":"9964_CR34","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1093\/brain\/awad275","volume":"146","author":"C Estevez-Fraga","year":"2023","unstructured":"Estevez-Fraga C, Altmann A, Parker CS, Scahill RI, Costa B, Chen Z et al (2023) Genetic topography and cortical cell loss in Huntington\u2019s disease link development and neurodegeneration. Brain 146(11):4532\u20134546","journal-title":"Brain"},{"key":"9964_CR35","doi-asserted-by":"crossref","unstructured":"Heinz A, Nabariya DK, Krau\u00df S (2023) Huntington\u2019s disease and neurodegeneration. Handbook of neurotoxicity. Springer, pp 1765\u20131787","DOI":"10.1007\/978-3-031-15080-7_226"},{"key":"9964_CR36","doi-asserted-by":"crossref","unstructured":"Jiang A, Handley RR, Lehnert K, Snell RG (2023) From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington\u2019s Disease Research. Int J Mol Sci. ;24(16)","DOI":"10.3390\/ijms241613021"},{"key":"9964_CR37","doi-asserted-by":"crossref","unstructured":"Pasko VI, Churkina AS, Shakhov AS, Kotlobay AA, Alieva IB (2022) Modeling of Neurodegenerative Diseases: \u2018Step by Step\u2019 and \u2018Network\u2019 Organization of the Complexes of Model Systems. Int J Mol Sci. ;24(1)","DOI":"10.3390\/ijms24010604"},{"issue":"1","key":"9964_CR38","first-page":"59","volume":"45","author":"S Rahmani","year":"2020","unstructured":"Rahmani S, Saberzadeh J, Takhshid MA (2020) The Hydroalcoholic Extract of Saffron protects PC12 cells against Aluminum-Induced cell death and oxidative stress in Vitro. Iran J Med Sci 45(1):59\u201366","journal-title":"Iran J Med Sci"},{"key":"9964_CR39","doi-asserted-by":"crossref","first-page":"1016559","DOI":"10.3389\/fnmol.2022.1016559","volume":"15","author":"D Xie","year":"2023","unstructured":"Xie D, Deng T, Zhai Z, Sun T, Xu Y (2023) The cellular model for Alzheimer\u2019s disease research: PC12 cells. Front Mol Neurosci 15:1016559","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"9964_CR40","first-page":"1353","volume":"22","author":"F Iranpak","year":"2019","unstructured":"Iranpak F, Saberzadeh J, Vessal M, Takhshid MA (2019) Sodium valproate ameliorates aluminum-induced oxidative stress and apoptosis of PC12 cells. Iran J Basic Med Sci 22(11):1353","journal-title":"Iran J Basic Med Sci"},{"key":"9964_CR41","doi-asserted-by":"crossref","unstructured":"Wiatrak B, Kubis-Kubiak A, Piwowar A, Barg E (2020) PC12 cell line: cell types, Coating of Culture vessels, differentiation and other Culture conditions. Cells. ;9(4)","DOI":"10.3390\/cells9040958"},{"key":"9964_CR42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcis.2020.04.040","volume":"574","author":"J Chen","year":"2020","unstructured":"Chen J, Huang D, Wang L, Hou J, Zhang H, Li Y et al (2020) 3D bioprinted multiscale composite scaffolds based on gelatin methacryloyl (GelMA)\/chitosan microspheres as a modular bioink for enhancing 3D neurite outgrowth and elongation. J Colloid Interface Sci 574:162\u2013173","journal-title":"J Colloid Interface Sci"},{"key":"9964_CR43","unstructured":"Hoorang A, Saberzadeh J, Iranpak F, Mohammadi-Bardbori A, Khorsand M, Takhshid MA (2020) The effect of sodium fluoride on aluminum-induced oxidative stress and apoptosis of PC12 in vitro. Fluoride. ;53"},{"issue":"8","key":"9964_CR44","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1039\/C8AY02672F","volume":"11","author":"BT Mehl","year":"2019","unstructured":"Mehl BT, Martin RS (2019) Integrating 3D cell culture of PC12 cells with microchip-based Electrochemical Detection. Anal Methods 11(8):1064\u20131072","journal-title":"Anal Methods"},{"issue":"7","key":"9964_CR45","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","volume":"73","author":"LA Greene","year":"1976","unstructured":"Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73(7):2424\u20132428","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9964_CR46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.18063\/ijb.v9i2.659","volume":"9","author":"X Dai","year":"2023","unstructured":"Dai X, Tian X, Gu S, Yang Y, Li H, Gao P et al (2023) Hybrid biofabrication of neurosecretory structures as a model for neurosecretion. Int J Bioprint 9(2):659","journal-title":"Int J Bioprint"},{"issue":"2","key":"9964_CR47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1748-1716.2007.01805.x","volume":"192","author":"RH Westerink","year":"2008","unstructured":"Westerink RH, Ewing AG (2008) The PC12 cell as model for neurosecretion. Acta Physiol (Oxf) 192(2):273\u2013285","journal-title":"Acta Physiol (Oxf)"},{"issue":"1","key":"9964_CR48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/acschemneuro.6b00208","volume":"8","author":"N Kinarivala","year":"2017","unstructured":"Kinarivala N, Shah K, Abbruscato TJ, Trippier PC (2017) Passage variation of PC12 cells results in inconsistent susceptibility to externally induced apoptosis. ACS Chem Neurosci 8(1):82\u201388","journal-title":"ACS Chem Neurosci"},{"key":"9964_CR49","doi-asserted-by":"crossref","unstructured":"Pokharel S, Lee CH, Gilyazova N, Ibeanu GC (2018) Analysis of Gene expression and neuronal phenotype in Neuroscreen-1 (NS-1) cells. Int J Biomed Investig. ;1(3)","DOI":"10.31531\/2581-4745.1000115"},{"issue":"11","key":"9964_CR50","first-page":"2643","volume":"33","author":"JL Biedler","year":"1973","unstructured":"Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33(11):2643\u20132652","journal-title":"Cancer Res"},{"key":"9964_CR51","doi-asserted-by":"crossref","unstructured":"Shipley MM, Mangold CA, Szpara ML (2016) Differentiation of the SH-SY5Y Human Neuroblastoma Cell line. J Visualized Experiments: JoVE. (108):53193","DOI":"10.3791\/53193"},{"key":"9964_CR52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","volume":"1078","author":"J Kovalevich","year":"2013","unstructured":"Kovalevich J, Langford D (2013) Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol 1078:9\u201321","journal-title":"Methods Mol Biol"},{"key":"9964_CR53","doi-asserted-by":"crossref","first-page":"111967","DOI":"10.1016\/j.fct.2021.111967","volume":"149","author":"RF Sim\u00f5es","year":"2021","unstructured":"Sim\u00f5es RF, Ferr\u00e3o R, Silva MR, Pinho SLC, Ferreira L, Oliveira PJ et al (2021) Refinement of a differentiation protocol using neuroblastoma SH-SY5Y cells for use in neurotoxicology research. Food Chem Toxicol 149:111967","journal-title":"Food Chem Toxicol"},{"key":"9964_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy H, Wieringa B, Martens GJ (2017) The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegeneration 12:1\u201311","journal-title":"Mol Neurodegeneration"},{"issue":"8","key":"9964_CR55","first-page":"1086","volume":"123","author":"HR Xie","year":"2010","unstructured":"Xie HR, Hu LS, Li GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease. Chin Med J (Engl) 123(8):1086\u20131092","journal-title":"Chin Med J (Engl)"},{"key":"9964_CR56","doi-asserted-by":"crossref","first-page":"943627","DOI":"10.3389\/fphar.2022.943627","volume":"13","author":"ER Martin","year":"2022","unstructured":"Martin ER, Gandawijaya J, Oguro-Ando A (2022) A novel method for generating glutamatergic SH-SY5Y neuron-like cells utilizing B-27 supplement. Front Pharmacol 13:943627","journal-title":"Front Pharmacol"},{"issue":"41","key":"9964_CR57","doi-asserted-by":"crossref","first-page":"38884","DOI":"10.1074\/jbc.M205518200","volume":"277","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P (2002) Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 277(41):38884\u201338894","journal-title":"J Biol Chem"},{"issue":"27","key":"9964_CR58","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1523\/JNEUROSCI.1746-05.2005","volume":"25","author":"J Lotharius","year":"2005","unstructured":"Lotharius J, Falsig J, van Beek J, Payne S, Dringen R, Brundin P et al (2005) Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 25(27):6329\u20136342","journal-title":"J Neurosci"},{"issue":"7","key":"9964_CR59","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/aps.2014.36","volume":"35","author":"X-m Zhang","year":"2014","unstructured":"Zhang X-m, Yin M, Zhang M-h (2014) Cell-based assays for Parkinson\u2019s disease using differentiated human LUHMES cells. Acta Pharmacol Sin 35(7):945\u2013956","journal-title":"Acta Pharmacol Sin"},{"key":"9964_CR60","doi-asserted-by":"crossref","unstructured":"Calamini B, Geyer N, Huss-Braun N, Bernhardt A, Harsany V, Rival P et al (2021) Development of a physiologically relevant and easily scalable LUHMES cell-based model of G2019S LRRK2-driven Parkinson\u2019s disease. Dis Model Mech. ;14(6)","DOI":"10.1242\/dmm.048017"},{"issue":"2","key":"9964_CR61","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1002\/btpr.2942","volume":"36","author":"KR Ko","year":"2020","unstructured":"Ko KR, Tam NW, Teixeira AG, Frampton JP (2020) SH-SY5Y and LUHMES cells display differential sensitivity to MPP+, tunicamycin, and epoxomicin in 2D and 3D cell culture. Biotechnol Prog 36(2):e2942","journal-title":"Biotechnol Prog"},{"key":"9964_CR62","doi-asserted-by":"crossref","unstructured":"Darbinian N (2021) Cultured cell line models of neuronal differentiation: NT2, PC12, and SK-N-MC. Neuronal Cell Culture: Methods and Protocols: Springer; pp. 25\u201338","DOI":"10.1007\/978-1-0716-1437-2_3"},{"issue":"1","key":"9964_CR63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/neuroglia2010008","volume":"2","author":"JK Sandhu","year":"2021","unstructured":"Sandhu JK, Ribecco-Lutkiewicz M, Abulrob A (2021) Molecular and functional characterization of Caveolae in mixed cultures of human NT-2 neurons and astrocytes. Neuroglia 2(1):68\u201388","journal-title":"Neuroglia"},{"issue":"13","key":"9964_CR64","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.3390\/ijms23137180","volume":"23","author":"ZS Liu","year":"2022","unstructured":"Liu ZS, Truong TT, Bortolasci CC, Spolding B, Panizzutti B, Swinton C et al (2022) Effects of psychotropic drugs on ribosomal genes and protein synthesis. Int J Mol Sci 23(13):7180","journal-title":"Int J Mol Sci"},{"issue":"21","key":"9964_CR65","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.3390\/ijms21218333","volume":"21","author":"CC Bortolasci","year":"2020","unstructured":"Bortolasci CC, Spolding B, Kidnapillai S, Connor T, Truong TT, Liu ZS et al (2020) Transcriptional effects of psychoactive drugs on genes involved in neurogenesis. Int J Mol Sci 21(21):8333","journal-title":"Int J Mol Sci"},{"key":"9964_CR66","doi-asserted-by":"crossref","first-page":"891605","DOI":"10.1155\/2011\/891605","volume":"2011","author":"MJ Eaton","year":"2011","unstructured":"Eaton MJ, Widerstr\u00f6m-Noga E, Wolfe SQ (2011) Subarachnoid transplant of the human neuronal hNT2.19 Serotonergic Cell Line attenuates behavioral hypersensitivity without affecting motor dysfunction after severe Contusive spinal cord Injury. Neurol Res Int 2011:891605","journal-title":"Neurol Res Int"},{"issue":"4","key":"9964_CR67","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/neuros\/nyaa531","volume":"88","author":"BJ Gu","year":"2021","unstructured":"Gu BJ, Kung DK, Chen HI (2021) Cell therapy for stroke: a mechanistic analysis. Neurosurgery 88(4):733\u2013745","journal-title":"Neurosurgery"},{"issue":"1","key":"9964_CR68","doi-asserted-by":"crossref","first-page":"e16174","DOI":"10.1371\/journal.pone.0016174","volume":"6","author":"DE Coyle","year":"2011","unstructured":"Coyle DE, Li J, Baccei M (2011) Regional differentiation of retinoic acid-induced human pluripotent embryonic carcinoma stem cell neurons. PLoS ONE 6(1):e16174","journal-title":"PLoS ONE"},{"issue":"5","key":"9964_CR69","doi-asserted-by":"crossref","first-page":"e36098","DOI":"10.1371\/journal.pone.0036098","volume":"7","author":"EJ Hill","year":"2012","unstructured":"Hill EJ, Jim\u00e9nez-Gonz\u00e1lez C, Tarczyluk M, Nagel DA, Coleman MD, Parri HR (2012) NT2 derived neuronal and astrocytic network signalling. PLoS ONE 7(5):e36098","journal-title":"PLoS ONE"},{"key":"9964_CR70","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00441-009-0783-0","volume":"336","author":"G Podrygajlo","year":"2009","unstructured":"Podrygajlo G, Tegenge MA, Gierse A, Paquet-Durand F, Tan S, Bicker G et al (2009) Cellular phenotypes of human model neurons (NT2) after differentiation in aggregate culture. Cell Tissue Res 336:439\u2013452","journal-title":"Cell Tissue Res"},{"key":"9964_CR71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.npep.2015.12.011","volume":"57","author":"Z Khoshdel","year":"2016","unstructured":"Khoshdel Z, Takhshid MA, Owji AA (2016) Effects of intrathecal amylin on formalin-induced nociception and on cAMP accumulation in the rat embryonic spinal cells. Neuropeptides 57:95\u2013100","journal-title":"Neuropeptides"},{"issue":"4","key":"9964_CR72","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.bjp.0706750","volume":"148","author":"MA Takhshid","year":"2006","unstructured":"Takhshid MA, Poyner DR, Chabot JG, Fournier A, Ma W, Zheng WH et al (2006) Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture. Br J Pharmacol 148(4):459\u2013468","journal-title":"Br J Pharmacol"},{"key":"9964_CR73","unstructured":"Al-Ali H, Blackmore M, Bixby JL, Lemmon VP (2014) High content screening with primary neurons. Assay Guidance Man [Internet]"},{"issue":"9","key":"9964_CR74","first-page":"1197","volume":"23","author":"A Mahmoodazdeh","year":"2020","unstructured":"Mahmoodazdeh A, Shafiee SM, Sisakht M, Khoshdel Z, Takhshid MA (2020) Adrenomedullin protects rat dorsal root ganglion neurons against doxorubicin-induced toxicity by ameliorating oxidative stress. Iran J Basic Med Sci 23(9):1197","journal-title":"Iran J Basic Med Sci"},{"key":"9964_CR75","doi-asserted-by":"crossref","unstructured":"Maguire AD, Plemel JR, Kerr BJ (2023) Enrichment of adult mouse dorsal root ganglia neuron cultures by immunopanning. JoVE (Journal Visualized Experiments). (192):e64603","DOI":"10.3791\/64603"},{"key":"9964_CR76","first-page":"1","volume":"1078","author":"J Gordon","year":"2013","unstructured":"Gordon J, Amini S, White MK (2013) General overview of neuronal cell culture. Methods in molecular biology. (Clifton NJ) 1078:1\u20138","journal-title":"(Clifton NJ)"},{"key":"9964_CR77","doi-asserted-by":"crossref","unstructured":"Gaven F, Marin P, Claeysen S (2014) Primary culture of mouse dopaminergic neurons. JoVE (Journal Visualized Experiments). (91):e51751","DOI":"10.3791\/51751"},{"key":"9964_CR78","doi-asserted-by":"crossref","unstructured":"Harischandra DS, Rokad D, Ghaisas S, Verma S, Robertson A, Jin H et al (2020) Enhanced differentiation of human dopaminergic neuronal cell model for preclinical translational research in Parkinson\u2019s disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1866(4):165533","DOI":"10.1016\/j.bbadis.2019.165533"},{"issue":"4","key":"9964_CR79","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41419-018-0468-2","volume":"9","author":"Y Che","year":"2018","unstructured":"Che Y, Hou L, Sun F, Zhang C, Liu X, Piao F et al (2018) Taurine protects dopaminergic neurons in a mouse Parkinson\u2019s disease model through inhibition of microglial M1 polarization. Cell Death Dis 9(4):435","journal-title":"Cell Death Dis"},{"issue":"7","key":"9964_CR80","first-page":"978","volume":"24","author":"M Sisakht","year":"2021","unstructured":"Sisakht M, Khoshdel Z, Mahmoodazdeh A, Shafiee SM, Takhshid MA (2021) Adrenomedullin increases cAMP accumulation and BDNF expression in rat DRG and spinal motor neurons. Iran J Basic Med Sci 24(7):978","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"9964_CR81","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23747","volume":"72","author":"EC Freundt","year":"2012","unstructured":"Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y et al (2012) Neuron-to\u2010neuron transmission of \u03b1\u2010synuclein fibrils through axonal transport. Ann Neurol 72(4):517\u2013524","journal-title":"Ann Neurol"},{"key":"9964_CR82","doi-asserted-by":"crossref","first-page":"1303111","DOI":"10.3389\/fneur.2023.1303111","volume":"14","author":"S Suresh","year":"2023","unstructured":"Suresh S, Singh SA, Rushendran R, Vellapandian C, Prajapati B (2023) Alzheimer\u2019s disease: the role of extrinsic factors in its development, an investigation of the environmental enigma. Front Neurol 14:1303111","journal-title":"Front Neurol"},{"issue":"1","key":"9964_CR83","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","volume":"19","author":"JA Trejo-Lopez","year":"2023","unstructured":"Trejo-Lopez JA, Yachnis AT, Prokop S (2023) Neuropathology of Alzheimer\u2019s disease. Neurotherapeutics 19(1):173\u2013185","journal-title":"Neurotherapeutics"},{"key":"9964_CR84","doi-asserted-by":"crossref","first-page":"1192562","DOI":"10.3389\/fpsyt.2023.1192562","volume":"14","author":"M Liu","year":"2023","unstructured":"Liu M, Xie X, Xie J, Tian S, Du X, Feng H et al (2023) Early-onset Alzheimer\u2019s disease with depression as the first symptom: a case report with literature review. Front Psychiatry 14:1192562","journal-title":"Front Psychiatry"},{"issue":"1","key":"9964_CR85","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41467-023-37304-3","volume":"14","author":"V Lau","year":"2023","unstructured":"Lau V, Ramer L, Tremblay M-\u00c8 (2023) An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer\u2019s disease. Nat Commun 14(1):1670","journal-title":"Nat Commun"},{"issue":"4","key":"9964_CR86","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E (2016) The cellular phase of Alzheimer\u2019s disease. Cell 164(4):603\u2013615","journal-title":"Cell"},{"issue":"12","key":"9964_CR87","doi-asserted-by":"crossref","first-page":"e0237122","DOI":"10.1371\/journal.pone.0237122","volume":"15","author":"A Guyon","year":"2020","unstructured":"Guyon A, Rousseau J, Lamothe G, Tremblay JP (2020) The protective mutation A673T in amyloid precursor protein gene decreases A\u03b2 peptides production for 14 forms of familial Alzheimer\u2019s Disease in SH-SY5Y cells. PLoS ONE 15(12):e0237122","journal-title":"PLoS ONE"},{"issue":"1","key":"9964_CR88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","volume":"12","author":"K Iqbal","year":"2016","unstructured":"Iqbal K, Liu F, Gong C-X (2016) Tau and neurodegenerative disease: the story so far. Nat Reviews Neurol 12(1):15\u201327","journal-title":"Nat Reviews Neurol"},{"issue":"1","key":"9964_CR89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/ijms24010359","volume":"24","author":"N Pie\u0144kowska","year":"2022","unstructured":"Pie\u0144kowska N, Fahnestock M, Mahadeo C, Zaborniak I, Chmielarz P, Bartosz G et al (2022) Induction of oxidative stress in SH-SY5Y cells by overexpression of htau40 and its mitigation by redox-active nanoparticles. Int J Mol Sci 24(1):359","journal-title":"Int J Mol Sci"},{"issue":"2","key":"9964_CR90","first-page":"241","volume":"14","author":"MA Takhshid","year":"2023","unstructured":"Takhshid MA, Davoudzadeh S, Noohi G, Naderi S, Zamani B (2023) Combined effects of Sodium Valproate and Lithium Chloride on Inducing apoptosis and Inhibiting Invasion of PC3 cells. Middle East J Cancer 14(2):241\u2013249","journal-title":"Middle East J Cancer"},{"issue":"1","key":"9964_CR91","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s11671-024-03973-2","volume":"19","author":"A Jimenez-Chavez","year":"2024","unstructured":"Jimenez-Chavez A, Pedroza-Herrera G, Betancourt-Reyes I, De Vizcaya Ruiz A, Masuoka-Ito D, Zapien JA et al (2024) Aluminum enhances the oxidative damage of ZnO NMs in the human neuroblastoma SH-SY5Y cell line. Discover Nano 19(1):36","journal-title":"Discover Nano"},{"key":"9964_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2017.09.114","volume":"96","author":"W Huang","year":"2017","unstructured":"Huang W, Cheng P, Yu K, Han Y, Song M, Li Y (2017) Hyperforin attenuates aluminum-induced A\u03b2 production and tau phosphorylation via regulating Akt\/GSK-3\u03b2 signaling pathway in PC12 cells. Biomed Pharmacother 96:1\u20136","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"9964_CR93","doi-asserted-by":"crossref","first-page":"8916","DOI":"10.1007\/s12035-018-0985-0","volume":"55","author":"S Gupta","year":"2018","unstructured":"Gupta S, Yadav K, Mantri SS, Singhal NK, Ganesh S, Sandhir R (2018) Evidence for compromised insulin signaling and neuronal vulnerability in experimental model of sporadic Alzheimer\u2019s Disease. Mol Neurobiol 55(12):8916\u20138935","journal-title":"Mol Neurobiol"},{"key":"9964_CR94","doi-asserted-by":"crossref","unstructured":"Lohou E, Sasaki NA, Boullier A, Duplantier M, Sonnet P (2019) Hydroxypyridinone-Diamine Hybrids as Potential Neuroprotective Agents in the PC12 Cell-Line Model of Alzheimer\u2019s Disease. Pharmaceuticals (Basel). ;12(4)","DOI":"10.3390\/ph12040162"},{"issue":"1","key":"9964_CR95","first-page":"59","volume":"45","author":"J Saberzadeh","year":"2020","unstructured":"Saberzadeh J, Takhshid MA (2020) The hydroalcoholic extract of saffron protects PC12 cells against aluminum-induced cell death and oxidative stress in vitro. Iran J Med Sci 45(1):59","journal-title":"Iran J Med Sci"},{"issue":"11","key":"9964_CR96","first-page":"1251","volume":"19","author":"J Saberzadeh","year":"2016","unstructured":"Saberzadeh J, Omrani M, Takhshid MA (2016) Protective effects of nimodipine and lithium against aluminum-induced cell death and oxidative stress in PC12 cells. Iran J Basic Med Sci 19(11):1251","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"9964_CR97","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405","journal-title":"Lancet Neurol"},{"issue":"1","key":"9964_CR98","doi-asserted-by":"crossref","first-page":"17841","DOI":"10.1038\/s41598-023-45220-1","volume":"13","author":"C Nopparat","year":"2023","unstructured":"Nopparat C, Boontor A, Kutpruek S, Govitrapong P (2023) The role of melatonin in amyloid beta-induced inflammation mediated by inflammasome signaling in neuronal cell lines. Sci Rep 13(1):17841","journal-title":"Sci Rep"},{"issue":"3","key":"9964_CR99","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20(3):148\u2013160","journal-title":"Nat Rev Neurosci"},{"issue":"15","key":"9964_CR100","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.3390\/molecules28155826","volume":"28","author":"QQ Pang","year":"2023","unstructured":"Pang QQ, Kim JH, Kim HY, Kim J-H, Cho EJ (2023) Protective effects and mechanisms of Pectolinarin against H2O2-Induced oxidative stress in SH-SY5Y neuronal cells. Molecules 28(15):5826","journal-title":"Molecules"},{"issue":"8","key":"9964_CR101","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/antiox10081231","volume":"10","author":"C Sharma","year":"2021","unstructured":"Sharma C, Kim SR (2021) Linking oxidative stress and proteinopathy in Alzheimer\u2019s disease. Antioxidants 10(8):1231","journal-title":"Antioxidants"},{"issue":"4","key":"9964_CR102","first-page":"111","volume":"25","author":"CH Chen","year":"2016","unstructured":"Chen CH, Joshi AU, Mochly-Rosen D (2016) The role of mitochondrial aldehyde dehydrogenase 2 (ALDH2) in neuropathology and neurodegeneration. Acta Neurol Taiwanica 25(4):111\u2013123","journal-title":"Acta Neurol Taiwanica"},{"issue":"5","key":"9964_CR103","doi-asserted-by":"crossref","first-page":"E258","DOI":"10.25011\/cim.v31i5.4872","volume":"31","author":"XL Li","year":"2008","unstructured":"Li XL, Cheng WD, Li J, Guo XL, Guo CJ, Meng XH et al (2008) Protective effect of estrogen on apoptosis in a cell culture model of Parkinson\u2019s disease. Clin Invest Med 31(5):E258\u2013E264","journal-title":"Clin Invest Med"},{"issue":"29","key":"9964_CR104","doi-asserted-by":"crossref","first-page":"14039","DOI":"10.1039\/D3NJ01746J","volume":"47","author":"M Li","year":"2023","unstructured":"Li M, Wang S, Fu C, Chen H, Su Y, Wu P et al (2023) Neuroprotective effects of salidroside against 6-OHDA-induced oxidative stress in PC12 cells. New J Chem 47(29):14039\u201314045","journal-title":"New J Chem"},{"issue":"2","key":"9964_CR105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00702-019-02133-6","volume":"127","author":"D Vare\u0161lija","year":"2020","unstructured":"Vare\u0161lija D, Tipton KF, Davey GP, McDonald AG (2020) 6-Hydroxydopamine: a far from simple neurotoxin. J Neural Transm (Vienna) 127(2):213\u2013230","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"9964_CR106","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","volume":"60","author":"MT Ibarra-Guti\u00e9rrez","year":"2023","unstructured":"Ibarra-Guti\u00e9rrez MT, Serrano-Garc\u00eda N, Orozco-Ibarra M (2023) Rotenone-induced model of Parkinson\u2019s disease: beyond mitochondrial complex I inhibition. Mol Neurobiol 60(4):1929\u20131948","journal-title":"Mol Neurobiol"},{"issue":"2","key":"9964_CR107","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jnc.16040","volume":"168","author":"A Carmona","year":"2024","unstructured":"Carmona A, Carboni E, Gomes LC, Roudeau S, Maass F, Lenz C et al (2024) Metal dyshomeostasis in the substantia nigra of patients with Parkinson\u2019s disease or multiple sclerosis. J Neurochem 168(2):128\u2013141","journal-title":"J Neurochem"},{"key":"9964_CR108","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brainres.2016.01.037","volume":"1635","author":"J Saberzadeh","year":"2016","unstructured":"Saberzadeh J, Arabsolghar R, Takhshid MA (2016) Alpha synuclein protein is involved in aluminum-induced cell death and oxidative stress in PC12 cells. Brain Res 1635:153\u2013160","journal-title":"Brain Res"},{"key":"9964_CR109","doi-asserted-by":"crossref","unstructured":"Burr\u00e9 J, Edwards RH, Halliday G, Lang AE, Lashuel HA, Melki R et al (2024) Research Priorities on the Role of \u03b1-Synuclein in Parkinson\u2019s Disease Pathogenesis. Mov Disord","DOI":"10.1002\/mds.29897"},{"key":"9964_CR110","doi-asserted-by":"crossref","first-page":"591475","DOI":"10.3389\/fnagi.2021.591475","volume":"13","author":"A Wilkaniec","year":"2021","unstructured":"Wilkaniec A, Lenkiewicz AM, Babiec L, Murawska E, J\u0119\u015bko HM, Cie\u015blik M et al (2021) Exogenous alpha-synuclein evoked parkin downregulation promotes mitochondrial dysfunction in neuronal cells. Implications for Parkinson\u2019s disease pathology. Front Aging Neurosci 13:591475","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"9964_CR111","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/ejn.13216","volume":"43","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Gong XG, Wang ZZ, Sun HM, Guo ZY, Hu JH et al (2016) Overexpression of DJ-1\/PARK7, the Parkinson\u2019s disease-related protein, improves mitochondrial function via akt phosphorylation on threonine 308 in dopaminergic neuron-like cells. Eur J Neurosci 43(10):1379\u20131388","journal-title":"Eur J Neurosci"},{"key":"9964_CR112","doi-asserted-by":"crossref","unstructured":"Feles S, Overath C, Reichardt S, Diegeler S, Schmitz C, Kronenberg J et al (2022) Streamlining culture conditions for the Neuroblastoma Cell Line SH-SY5Y: a prerequisite for functional studies. Methods Protoc. ;5(4)","DOI":"10.3390\/mps5040058"},{"key":"9964_CR113","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neurobiolaging.2023.02.010","volume":"126","author":"FJ Arnold","year":"2023","unstructured":"Arnold FJ, Burns M, Chiu Y, Carvalho J, Nguyen AD, Ralph PC et al (2023) Chronic BMAA exposure combined with TDP-43 mutation elicits motor neuron dysfunction phenotypes in mice. Neurobiol Aging 126:44\u201357","journal-title":"Neurobiol Aging"},{"issue":"1","key":"9964_CR114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12640-017-9743-8","volume":"33","author":"R van Onselen","year":"2018","unstructured":"van Onselen R, Venables L, van de Venter M, Downing TG (2018) \u03b2-N-Methylamino-L-Alanine toxicity in PC12: Excitotoxicity vs. Misincorporation. Neurotox Res 33(1):15\u201323","journal-title":"Neurotox Res"},{"key":"9964_CR115","doi-asserted-by":"crossref","unstructured":"Rogers CQ, Ramirez M, Landon CS, DeBlasi JM, Koutnik AP, Ari C et al (2023) A glutamate scavenging protocol combined with Deanna Protocol in SOD1-G93A mouse model of ALS. Nutrients. ;15(8)","DOI":"10.3390\/nu15081821"},{"issue":"4","key":"9964_CR116","doi-asserted-by":"crossref","first-page":"468","DOI":"10.17113\/ftb.52.04.14.3622","volume":"52","author":"CH Chang","year":"2014","unstructured":"Chang CH, Chen HX, Y\u00fc G, Peng CC, Peng RY (2014) Curcumin-protected PC12 cells against Glutamate-Induced oxidative toxicity. Food Technol Biotechnol 52(4):468\u2013478","journal-title":"Food Technol Biotechnol"},{"issue":"2","key":"9964_CR117","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bmc.2011.11.039","volume":"20","author":"W Zhang","year":"2012","unstructured":"Zhang W, Benmohamed R, Arvanites AC, Morimoto RI, Ferrante RJ, Kirsch DR et al (2012) Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cells. Bioorg Med Chem 20(2):1029\u20131045","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"9964_CR118","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/toxsci\/kfy267","volume":"167","author":"PEA Ash","year":"2019","unstructured":"Ash PEA, Dhawan U, Boudeau S, Lei S, Carlomagno Y, Knobel M et al (2019) Heavy metal neurotoxicants induce ALS-Linked TDP-43 Pathology. Toxicol Sci 167(1):105\u2013115","journal-title":"Toxicol Sci"},{"issue":"7","key":"9964_CR119","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/ml3000963","volume":"3","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Benmohamed R, Zhang W, Kim J, Edgerly CK, Zhu Y et al (2012) Chiral cyclohexane 1,3-diones as inhibitors of mutant SOD1-dependent protein aggregation for the treatment of ALS. ACS Med Chem Lett 3(7):584\u2013587","journal-title":"ACS Med Chem Lett"},{"key":"9964_CR120","doi-asserted-by":"crossref","first-page":"611601","DOI":"10.3389\/fcell.2021.611601","volume":"9","author":"Q Ding","year":"2021","unstructured":"Ding Q, Chaplin J, Morris MJ, Hilliard MA, Wolvetang E, Ng DCH et al (2021) TDP-43 mutation affects stress Granule Dynamics in Differentiated NSC-34 Motoneuron-Like cells. Front cell Dev Biology 9:611601","journal-title":"Front cell Dev Biology"},{"issue":"1","key":"9964_CR121","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13287-018-1048-1","volume":"9","author":"X Sun","year":"2018","unstructured":"Sun X, Song J, Huang H, Chen H, Qian K (2018) Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells. Stem Cell Res Ther 9(1):315","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"9964_CR122","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.3390\/molecules20033496","volume":"20","author":"VK Wong","year":"2015","unstructured":"Wong VK, Wu AG, Wang JR, Liu L, Law BY (2015) Neferine attenuates the protein level and toxicity of mutant huntingtin in PC-12 cells via induction of autophagy. Molecules 20(3):3496\u20133514","journal-title":"Molecules"},{"issue":"12","key":"9964_CR123","doi-asserted-by":"crossref","first-page":"101871","DOI":"10.1016\/j.jsps.2023.101871","volume":"31","author":"A Ramadan","year":"2023","unstructured":"Ramadan A, Mohammed A, Elnour AA, Sadeq A, Al Mazrouei N, Alkaabi M et al (2023) The flavonoid luteolin reduces mutant huntingtin aggregation and cytotoxicity in huntingtin-mutated neuroblastoma cells. Saudi Pharm J 31(12):101871","journal-title":"Saudi Pharm J"},{"issue":"1","key":"9964_CR124","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s13311-019-00805-5","volume":"17","author":"NH Sayed","year":"2020","unstructured":"Sayed NH, Fathy N, Kortam MA, Rabie MA, Mohamed AF, Kamel AS (2020) Vildagliptin attenuates Huntington\u2019s disease through activation of GLP-1 receptor\/PI3K\/Akt\/BDNF pathway in 3-nitropropionic acid rat model. Neurotherapeutics 17(1):252\u2013268","journal-title":"Neurotherapeutics"},{"key":"9964_CR125","doi-asserted-by":"crossref","unstructured":"Pruccoli L, Breda C, Teti G, Falconi M, Giorgini F, Tarozzi A (2021) Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington\u2019s Disease Models. Pharmaceuticals (Basel). ;14(10)","DOI":"10.3390\/ph14101044"},{"issue":"3","key":"9964_CR126","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5483\/BMBRep.2022-0157","volume":"56","author":"E Li","year":"2023","unstructured":"Li E, Choi J, Sim H-R, Kim J, Jun JH, Kyung J et al (2023) A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of Huntington\u2019s disease. BMB Rep 56(3):178","journal-title":"BMB Rep"},{"issue":"3","key":"9964_CR127","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/1673-5374.320970","volume":"17","author":"Y Ju","year":"2022","unstructured":"Ju Y, Tam KY (2022) Pathological mechanisms and therapeutic strategies for Alzheimer\u2019s disease. Neural Regeneration Res 17(3):543\u2013549","journal-title":"Neural Regeneration Res"},{"issue":"1","key":"9964_CR128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ca.23792","volume":"35","author":"NS Erekat","year":"2022","unstructured":"Erekat NS (2022) Apoptosis and its therapeutic implications in neurodegenerative diseases. Clin Anat 35(1):65\u201378","journal-title":"Clin Anat"},{"issue":"10","key":"9964_CR129","doi-asserted-by":"crossref","first-page":"e0287817","DOI":"10.1371\/journal.pone.0287817","volume":"18","author":"G-H Zhang","year":"2023","unstructured":"Zhang G-H, Chin KL, Yan S-Y, Pare R (2023) Antioxioxidant and antiapoptotic effects of Thymosin \u03b24 in A\u03b2-induced SH-SY5Y cells via the 5-HTR1A\/ERK axis. PLoS ONE 18(10):e0287817","journal-title":"PLoS ONE"},{"key":"9964_CR130","unstructured":"Kaya-Sezginer E, KIRLANGI\u00c7 \u00d6F, KARAKAYA C, \u00d6ren S, Fatsa T, \u00d6zg\u00fcrta\u015f T (2023) Apoptosis inducing effect of sodium butyrate and cisplatin alone or in combination on SH-SY5Y human neuroblastoma cells. J Res Pharm. ;27(1)"},{"issue":"1","key":"9964_CR131","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Therapy 8(1):267","journal-title":"Signal Transduct Target Therapy"},{"key":"9964_CR132","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y) 4:575\u2013590","journal-title":"Alzheimers Dement (N Y)"},{"issue":"5","key":"9964_CR133","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1089\/ars.2019.7952","volume":"34","author":"AWK Yeung","year":"2021","unstructured":"Yeung AWK, Tzvetkov NT, Georgieva MG, Ognyanov IV, Kordos K, J\u00f3\u017awik A et al (2021) Reactive oxygen species and their impact in neurodegenerative diseases: Literature Landscape Analysis. Antioxid Redox Signal 34(5):402\u2013420","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"9964_CR134","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1007\/s12035-023-03329-4","volume":"60","author":"I Korczowska-\u0141\u0105cka","year":"2023","unstructured":"Korczowska-\u0141\u0105cka I, Hur\u0142a M, Banaszek N, Kobylarek D, Szymanowicz O, Kozubski W et al (2023) Selected biomarkers of oxidative stress and energy metabolism disorders in neurological diseases. Mol Neurobiol 60(7):4132\u20134149","journal-title":"Mol Neurobiol"},{"issue":"1","key":"9964_CR135","first-page":"6670656","volume":"2021","author":"AR Zangeneh","year":"2021","unstructured":"Zangeneh AR, Takhshid MA, Ranjbaran R, Maleknia M, Meshkibaf MH (2021) Diverse effect of vitamin C and N-Acetylcysteine on Aluminum\u2010Induced Eryptosis. Biochem Res Int 2021(1):6670656","journal-title":"Biochem Res Int"},{"key":"9964_CR136","doi-asserted-by":"crossref","unstructured":"Manoharan S, Guillemin GJ, Abiramasundari RS, Essa MM, Akbar M, Akbar MD (2016) The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer\u2019s Disease, Parkinson\u2019s Disease, and Huntington\u2019s Disease: A Mini Review. Oxidative medicine and cellular longevity. ;2016:8590578","DOI":"10.1155\/2016\/8590578"},{"key":"9964_CR137","doi-asserted-by":"crossref","unstructured":"Ferreira J, Santos S, Pereira H (2020) In Vitro Screening for Acetylcholinesterase Inhibition and Antioxidant Activity of Quercus suber Cork and Corkback Extracts. Evidence-based complementary and alternative medicine: eCAM. ;2020:3825629","DOI":"10.1155\/2020\/3825629"},{"key":"9964_CR138","doi-asserted-by":"crossref","unstructured":"Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G et al (2021) Role of Monoamine Oxidase Activity in Alzheimer\u2019s Disease: An Insight into the Therapeutic Potential of Inhibitors. Molecules. ;26(12)","DOI":"10.3390\/molecules26123724"},{"issue":"3","key":"9964_CR139","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/17460441.2023.2293158","volume":"19","author":"M Pandey","year":"2024","unstructured":"Pandey M, Karmakar V, Majie A, Dwivedi M, Md S, Gorain B (2024) The SH-SY5Y cell line: a valuable tool for Parkinson\u2019s disease drug discovery. Expert Opin Drug Discov 19(3):303\u2013316","journal-title":"Expert Opin Drug Discov"},{"key":"9964_CR140","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40120-020-00218-z","volume":"9","author":"NC Barman","year":"2020","unstructured":"Barman NC, Khan NM, Islam M, Nain Z, Roy RK, Haque A et al (2020) CRISPR-Cas9: a promising genome editing therapeutic tool for Alzheimer\u2019s disease\u2014A narrative review. Neurol Therapy 9:419\u2013434","journal-title":"Neurol Therapy"},{"key":"9964_CR141","doi-asserted-by":"crossref","first-page":"105009","DOI":"10.1016\/j.neuint.2021.105009","volume":"145","author":"H Alrashidi","year":"2021","unstructured":"Alrashidi H, Eaton S, Heales S (2021) Biochemical characterization of proliferative and differentiated SH-SY5Y cell line as a model for Parkinson\u2019s disease. Neurochem Int 145:105009","journal-title":"Neurochem Int"},{"issue":"6","key":"9964_CR142","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.4103\/1673-5374.358621","volume":"18","author":"LF Hoffmann","year":"2023","unstructured":"Hoffmann LF, Martins A, Majolo F, Contini V, Laufer S, Goettert MI (2023) Neural regeneration research model to be explored: SH-SY5Y human neuroblastoma cells. Neural Regen Res 18(6):1265\u20131266","journal-title":"Neural Regen Res"},{"issue":"11","key":"9964_CR143","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/brain\/awaa268","volume":"143","author":"P Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou P, Rauti R, Voulgaris D, Shlomy I, Maoz BM, Herland A (2020) Recent progress in translational engineered in vitro models of the central nervous system. Brain 143(11):3181\u20133213","journal-title":"Brain"},{"key":"9964_CR144","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuro.2022.07.008","volume":"92","author":"L Lopez-Suarez","year":"2022","unstructured":"Lopez-Suarez L, Awabdh SA, Coumoul X, Chauvet C (2022) The SH-SY5Y human neuroblastoma cell line, a relevant in vitro cell model for investigating neurotoxicology in human: focus on organic pollutants. Neurotoxicology 92:131\u2013155","journal-title":"Neurotoxicology"},{"issue":"21","key":"9964_CR145","doi-asserted-by":"crossref","first-page":"jcs249789","DOI":"10.1242\/jcs.249789","volume":"133","author":"G Lauter","year":"2020","unstructured":"Lauter G, Coschiera A, Yoshihara M, Sugiaman-Trapman D, Ezer S, Sethurathinam S et al (2020) Differentiation of ciliated human midbrain-derived LUHMES neurons. J Cell Sci 133(21):jcs249789","journal-title":"J Cell Sci"},{"issue":"1","key":"9964_CR146","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12974-020-01819-z","volume":"17","author":"N Goshi","year":"2020","unstructured":"Goshi N, Morgan RK, Lein PJ, Seker E (2020) A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation. J Neuroinflammation 17(1):155","journal-title":"J Neuroinflammation"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09964-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09964-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09964-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:26:43Z","timestamp":1738729603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09964-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9964"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09964-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1024"}}